Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in Stage III colon cancer
Phase 2
Recruiting
- Conditions
- Colon cancer
- Registration Number
- JPRN-UMIN000006750
- Lead Sponsor
- agoya Surgical Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active double cancer 2) Synchronous or metachronous colorectal cancer 3) Severe postoperative complications 4) With following complications a) Uncontrollable diabetes mellitus b) Uncontrollable hypertension c) Mycardial infraction within 6 months d) Liver cirrhosis e) Interstitial pneumonia, pulmonary fibrosis, or severe emphysema 5) Pregnant or nursing women, women who wish to become pregnant and men who are planning partners' pregnancy 6) History of mental disorder or treating it at the moment 7) Administration contraindication of TS-1 8) Continuous use of warfarin potassium 9) History of severe allergy 10) Not suitable for participation with any other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method